OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $201,988 Invested

2022

The University of Edinburgh

Neil McKenzie, PhD, CChem, MSc, BSc(Hons)

The development and evaluation of a clinical RT-QuIC test for diagnosis of TDP-43 linked Fronto-temporal dementias

  • Funding Amount: $201,988
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: TDP-43
  • Status: Active